Targeting fear memory by disrupting the process of reconsolidation: A new intervention for panic disorder.
- Conditions
- Anxiety Disorder.Panic Disorder10002861
- Registration Number
- NL-OMON47318
- Lead Sponsor
- niversiteit van Amsterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 60
A primary diagnosis of panic disorder according to DSM-V.
* other relevant treatment for panic disorder at the time of study - e.g., CBT
* diagnosis of psychosis
* use of psychotropic medication
* A current state of asthma or COPD, which necessitates medication use
* history of respiratory diseases (asthma or COPD in the past does not lead to exclusion)
* history of cardiovascular diseases or irregular heartbeat
* history of cerebrovascular diseases
* history of severe allergic reactions to propranolol, which necessitated hospitalisation
* cerebral aneurysm among first-degree relatives
* Heart rate < 60. If heart rate is between 55 and 60 bpm, but exceeds 60 bpm after a minute of moderate physical activity (2-step test), the participant can be included. A heart rate of <50 in participants who spend 7 hours or more per week engaged in physical exercise will be the resting heart rate limit. A heart rate of <50 will lead to immediate exclusion (no 2-step test).
* BP < 100/60 or BP > 180/100
* epilepsy
* any medication contra-indicative of the use of propranolol
* pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Individual scores on the Panic Disorder Severity Scale.<br /><br>Presence of panic disorder according to DSM V criteria</p><br>
- Secondary Outcome Measures
Name Time Method <p>Individual scores on the Panic Appraisal Inventory, Mobility Inventory, Body<br /><br>Sensations Questionnaire, and Agoraphobic Cognitions Questionnaire will be used<br /><br>as secondary study parameters. In addition, willingness to inhale 35% CO2 is<br /><br>used as a secondary study parameter.</p><br>